CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $17,224,593
- in 1 filing
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-31 | Novo A/S 10% owner | Purchase | +50,000 | $15.00 | $750K | 3,033,504 |
| 2017-01-31 | Novo A/S 10% owner | Conversion · Series B Preferred Stock | −1,428,571 | 0 | ||
| 2017-01-31 | Novo A/S 10% owner | Conversion · Series C Preferred Stock | −486,820 | 0 | ||
| 2017-01-31 | Novo A/S 10% owner | Conversion · Series C-1 Preferred Stock | −312,986 | 0 | ||
| 2017-01-31 | Novo A/S 10% owner | Conversion · Series D Preferred Stock | −673,454 | 0 | ||
| 2017-01-31 | Novo A/S 10% owner | Option exercise · Series C Preferred Stock Warrant (Right to Buy) | −117,235 | 0 | ||
| 2017-01-31 | Topper James N Director | Conversion | +2,228,377 | 2,228,377 | ||
| 2017-01-31 | Topper James N Director | Conversion | +733,740 | 733,740 | ||
| 2017-01-31 | Topper James N Director | Conversion | +209,095 | 209,095 | ||
| 2017-01-31 | Topper James N Director | Purchase | +311,291 | $15.00 | $4.7M | 1,045,031 |
| 2017-01-31 | Topper James N Director | Purchase | +88,709 | $15.00 | $1.3M | 297,804 |
| 2017-01-31 | Topper James N Director | Conversion · Series B Preferred Stock | −1,428,571 | 0 | ||
| 2017-01-31 | Topper James N Director | Conversion · Series C Preferred Stock | −604,055 | 0 | ||
| 2017-01-31 | Topper James N Director | Conversion · Series C-1 Preferred Stock | −195,751 | 0 | ||
| 2017-01-31 | Topper James N Director | Conversion · Series D Preferred Stock | −733,740 | 0 | ||
| 2017-01-31 | Topper James N Director | Conversion · Series D Preferred Stock | −209,095 | 0 | ||
| 2017-01-31 | Gallagher Carol Giltner Director | Conversion | +64,296 | 64,296 | ||
| 2017-01-31 | Gallagher Carol Giltner Director | Conversion · Series C Preferred Stock | −42,857 | 0 | ||
| 2017-01-31 | Gallagher Carol Giltner Director | Conversion · Series D Preferred Stock | −21,439 | 0 | ||
| 2017-01-31 | Lydon Nicholas Director | Conversion | +203,625 | 270,957 |
Page 34 of 36 · 714 trades